Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases

Cancer Research

Volumn 60, Issue 16, 2000, Pages 4629-4637

  Attiga, Fadwa A ^a   Fernandez, Patricia M ^b   Weeraratna, Ashani T ^b   Manyak, Michael J ^a   Patierno, Steven R ^b  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 BROMOPHENACYL BROMIDE; CYCLOOXYGENASE 2 INHIBITOR; ESCULETIN; GELATINASE A; GELATINASE B; IBUPROFEN; INDOMETACIN; MATRIX METALLOPROTEINASE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; MALE GENITAL TRACT CANCER; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; PROSTATE CANCER; PROSTATE DISEASE; TUMOR CELL;

3T3 CELLS; ACETOPHENONES; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONIC ACID; CELL MOVEMENT; CELL SURVIVAL; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; EICOSANOIDS; ENZYME INHIBITORS; HUMANS; IBUPROFEN; ISOENZYMES; LIPOXYGENASE; LIPOXYGENASE INHIBITORS; MALE; MATRIX METALLOPROTEINASES; MEMBRANE PROTEINS; MICE; NEOPLASM INVASIVENESS; NITROBENZENES; PHOSPHOLIPASES A; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; PROSTATIC NEOPLASMS; SULFONAMIDES; TISSUE INHIBITOR OF METALLOPROTEINASES; TUMOR CELLS, CULTURED; UMBELLIFERONES;

EID: 0034662627     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Cancer statistics, 1998
2. Prostate cancer: Where are we and where are we going?
3. Loss of basement membrane components by invasive tumors but not by their benign counterparts
4. Use of a reconstituted basement membrane to study the invasiveness of tumor cells
5. Prostaglandins and cancer: A review of tumor initiation through tumor metastasis
6. Arachidonic acid in cell signaling
7. Eicosanoids and tumor cell metastatis
8. Essential fatty acid distribution in the plasma and tissue phospholipids of patients with benign and malignant prostatic disease
9. Arachidonic acid metabolism in benign and malignant prostatic tissue in vitro: Effects of fatty acids and cyclooxygenase inhibitors
10. Elevated 12-lipoxygenase mRNA expression correlates with advanced stage and poor differentiation of human prostate cancer
11. Arachidonic acid metabolism and cancer of the prostate
12. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells
13. Safety profile: Fifteen years of clinical experience with ibuprofen
14. Chemopreventive effects of NSAIDs against colorectal cancer: Regulation of apoptosis and mitosis by COX-1 and COX-2
15. Non-steroidal anti-inflammatory drugs and prostate cancer progression
16. Immunotherapy of mammary adenocarcinoma metastases in C3H/HeN mice with chronic administration of cyclo-oxygenase inhibitors alone or in combination with IL-2
17. Antitumoral activity of indomethacin on experimental esophageal tumors
18. Inhibition of cyclooxygenase: A novel approach to cancer prevention
19. Isolation of a human prostate carcinoma cell line (DU 145)
20. Establishment and characterization of a human prostatic carcinoma cell line (PC-3)
21. A rapid in vitro assay for quantitating the invasive potential of tumor cells
22. Assay for the study of human cancer cell invasion and metastasis
23. Recombinant human uteroglobin inhibits the in vitro invasiveness of human metastatic prostate tumor cells and the release of arachidonic acid stimulated by fibroblast-conditioned medium
24. Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors
25. Zymography: A single-step staining method for quantitation of proteolytic activity on substrate gels
26. r 72, 000) expression in human prostate: Benign and malignant tissue
27. Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: Contribution of stromal cells to their production and correlation with metastasis
28. Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: Effects on cell cycle and apoptosis
29. Effects of fatty acids on invasion through reconstituted basement membrane ("Matrigel") by a human breast cancer cell line
30. Effects of ibuprofen on the in vitro invasiveness of a human transitional cell carcinoma
31. Identification of arachidonic acid pathways required for the invasive and metastatic activity of malignant tumor cells
32. Eicosanoids and cancer
33. Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors
34. Prostaglandin production by murine tumors as a predictor for therapeutic response to indomethacin
35. Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention
36. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors
37. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
38. Arachidonic acid stimulates prostate cancer cell growth: Critical role of 5-lipoxygenase
39. 12(S)-HETE enhancement of prostate tumor cell invasion: Selective role of PKC α
40. Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis
41. r 92, 000 type IV collagenase expression in a squamous cell carcinoma cell line by fibroblasts
42. Induction of matrix metalloproteinase 9 expression in breast carcinoma cells by a soluble factor from fibroblasts
43. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium
44. Matrix metalloproteinases: A review
45. In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancer
46. Evidence for increased activated metalloproteinase 2 (MMP-2a) expression associated with human prostate cancer progression
47. Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia
48. Molecular biology of prostanoid biosynthetic enzymes and receptors
49. Peroxisome proliferator-activated receptors (PPARS) and carcinogenesis
50. The nuclear eicosanoid receptor. PPARγ, is aberrantly expressed in colonic cancers
51. Ligand for peroxisome proliferator-activated receptor γ (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo
52. Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs
53. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation